134 related articles for article (PubMed ID: 26629110)
1. Prognostic significance of EZH2 expression in patients with digestive cancers: a meta-analysis.
Wang W; Wang F; Zong G; Liu R; Zhang Y; Luan Y; Xu L; Xuan J
Int J Clin Exp Med; 2015; 8(9):16043-9. PubMed ID: 26629110
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta-analysis.
Wang Y; Gao F; Zhao M; Li B; Xing D; Wang J; Yang Y
J Cell Mol Med; 2016 May; 20(5):836-41. PubMed ID: 26859127
[TBL] [Abstract][Full Text] [Related]
3. The role of EZH2 in overall survival of colorectal cancer: a meta-analysis.
Vilorio-Marqués L; Martín V; Diez-Tascón C; González-Sevilla MF; Fernández-Villa T; Honrado E; Davila-Batista V; Molina AJ
Sci Rep; 2017 Oct; 7(1):13806. PubMed ID: 29061982
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.
Wang X; Zhao H; Lv L; Bao L; Wang X; Han S
Sci Rep; 2016 Jan; 6():19239. PubMed ID: 26754405
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Caspase-3 expression in cancers of digestive tract: a meta-analysis and systematic review.
Chen H; Yang X; Feng Z; Tang R; Ren F; Wei K; Chen G
Int J Clin Exp Med; 2015; 8(7):10225-34. PubMed ID: 26379814
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
[TBL] [Abstract][Full Text] [Related]
7. Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis.
Guo L; Yang TF; Liang SC; Guo JX; Wang Q
Tumour Biol; 2014 Jul; 35(7):6649-56. PubMed ID: 24705718
[TBL] [Abstract][Full Text] [Related]
8. Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.
Chen S; Huang L; Sun K; Wu D; Li M; Li M; Zhong B; Chen M; Zhang S
PLoS One; 2015; 10(5):e0125480. PubMed ID: 25974088
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of FoxM1 expression in non-small cell lung cancer.
Sun Q; Dong M; Chen Y; Zhang J; Qiao J; Guo X
J Thorac Dis; 2016 Jun; 8(6):1269-73. PubMed ID: 27293846
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.
Peng L; Zhou Y; Wang Y; Mou H; Zhao Q
PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of vascular endothelial growth factor A expression in gastric cancer: a meta-analysis.
Ji YN; Wang Q; Li Y; Wang Z
Tumour Biol; 2014 Mar; 35(3):2787-93. PubMed ID: 24234334
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer.
He LJ; Cai MY; Xu GL; Li JJ; Weng ZJ; Xu DZ; Luo GY; Zhu SL; Xie D
Asian Pac J Cancer Prev; 2012; 13(7):3173-8. PubMed ID: 22994729
[TBL] [Abstract][Full Text] [Related]
13. EZH2 overexpression is associated with poor prognosis in patients with glioma.
Zhang Y; Yu X; Chen L; Zhang Z; Feng S
Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940
[TBL] [Abstract][Full Text] [Related]
14. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
[TBL] [Abstract][Full Text] [Related]
15. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
Ha SY; Kim SH
Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
[TBL] [Abstract][Full Text] [Related]
16. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
[TBL] [Abstract][Full Text] [Related]
17. Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms.
Zhang Q; Han Q; Zi J; Ma J; Song H; Tian Y; McGrath M; Song C; Ge Z
Genes Dis; 2019 Sep; 6(3):276-281. PubMed ID: 32042866
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis.
Jiang T; Wang Y; Zhou F; Gao G; Ren S; Zhou C
Oncotarget; 2016 Jan; 7(4):4584-97. PubMed ID: 26683709
[TBL] [Abstract][Full Text] [Related]
19. VEGF-C expression is associated with the poor survival in gastric cancer tissue.
Cao W; Fan R; Yang W; Wu Y
Tumour Biol; 2014 Apr; 35(4):3377-83. PubMed ID: 24307624
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.
Dong M; Fan XJ; Chen ZH; Wang TT; Li X; Chen J; Lin Q; Wen JY; Ma XK; Wei L; Ruan DY; Lin ZX; Liu Q; Wu XY; Wan XB
Oncol Rep; 2014 Sep; 32(3):1101-7. PubMed ID: 25017254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
